this page only  
Join BIO   |   Member Directory   |    Contact BIO    
Biotechnology Industry Organization

Home
About BIO
Conferences & Events
Past BIO Events
Industry Calendar
State/Int'l Calendar
Members.BIO.org
BIO News Online
BIO Bulletins
Suggestion Box
Membership Directory
BIO Videos
News & Media
BIO Blogs & Podcasts
National Issues
Health
Food & Agriculture
Industrial & Environmental
Bioethics
Intellectual Property
Regulatory
• Tax & Financial
State & Local Issues
State by State Initiatives
Letters, Testimony & Comments
Speeches & Publications
Industry At-a-Glance
Business & Finance
BIO News


Saturday, November 21, 2009

Tax & Financial | Overview

overviewlegislative issues
accounting issuesnet operating losses
archivesbir
collaborationsstock options
fundingtax issues
Tax & Financial Issues

SBIR
Sarbanes-Oxley
Sec 382 Tax Bill
Stock Options
Orphan Drug Tax Credit
R&D Tax Credit
Agency Appropriations
Accounting Issues

Tax & Capital Formation Challenges for the Biotechnology Industry

Supporting the biotechnology industry's growth has been central to BIO's mission since the organization's founding in 1993. That growth begins with the success of individual biotech companies, most of which are small businesses.

A majority employ 50 people or fewer and have yet to turn a profit, according to a 2003 U.S. Commerce Department survey.

Making such business models work requires the support of larger industrial partners, investors, and government laws and regulations that encourage and reward innovation.

BIO: The Complete Connection
Learn more about the Biotechnology Industry Organization (BIO)
Read the Emerging Companies Brochure (336 KB PDF)
Read the Complete Connection Brochure (862 KB PDF)




contact us | terms of use | privacy policy
© 2009 | Biotechnology Industry Organization | 1201 Maryland Ave., SW, Ste. 900 | Washington, D.C. 20024